购物车
- 全部删除
- 您的购物车当前为空
c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity.
c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 16,100 | 10-14周 | |
50 mg | ¥ 21,300 | 10-14周 | |
100 mg | ¥ 27,500 | 10-14周 |
产品描述 | c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity. |
靶点活性 | c-Met:0.6 nM |
体外活性 | c-Met-IN-2 (Compound 14) also shows weak activity on other kinases, with IC50s of 731 nM (RON), 1075 nM (AxI), 18364 nM (VEGFR2), 2357 nM (PDGFRa), 5396 nM (c-Kit), 17056 nM (c-Src). |
体内活性 | In mice bearing H1993 tumors, c-Met-IN-2 (0.1, 1, 10 mg/kg, p.o., once daily) significantly reduces the volume of tumors. c-Met-IN-2 has a similar effect in SNU-5 xenograft model via oral administration at 0.3, 1 and 3 mg/kg. |
分子量 | 484.49 |
分子式 | C24H21FN10O |
CAS No. | 1635406-73-3 |
密度 | 1.55 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容